Trademark: 79367341
Status Date
Tuesday, December 5, 2023
Registration Number
7232811
Registration Date
Tuesday, December 5, 2023
Filing Date
Monday, February 27, 2023
Published for Opposition
Tuesday, September 19, 2023
5 Anti-infectives; pharmaceutical preparations for the treatment of inflammation; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antiviral pharmaceuticals; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of dermatological diseases; inhaled pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of diseases of the autoimmune system; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of asthma
The mark consists of a stylized diamond formed by four intersecting lines, two in coral and two in magenta, two straight lines in magenta and a zig-zag line in magenta; the two intersecting lines in coral define the left and right corners of the diamond while the two straight lines define the top and bottom corners of the diamond; the color white is meant to show transparent areas and is not a feature of the mark.
The color(s) magenta and coral is/are claimed as a feature of the mark.
Mar 26, 2024
Final Decision Transaction Processed By Ib
Mar 7, 2024
Final Disposition Notice Sent To Ib
Mar 7, 2024
Final Disposition Processed
Mar 5, 2024
Final Disposition Notice Created, To Be Sent To Ib
Dec 5, 2023
Notice Of Registration Confirmation Emailed
Dec 5, 2023
Registered-Principal Register
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 19, 2023
Published For Opposition
Sep 18, 2023
Notification Processed By Ib
Aug 30, 2023
Notification Of Possible Opposition Sent To Ib
Aug 30, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Aug 15, 2023
Refusal Processed By Ib
Aug 10, 2023
Approved For Pub - Principal Register
Aug 8, 2023
Teas/Email Correspondence Entered
Aug 8, 2023
Correspondence Received In Law Office
Aug 8, 2023
Teas Response To Office Action Received
Jul 21, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jul 21, 2023
Refusal Processed By Mpu
Jun 15, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Jun 14, 2023
Non-Final Action Written
Jun 12, 2023
Assigned To Examiner
Apr 21, 2023
Application Filing Receipt Mailed
Apr 17, 2023
New Application Office Supplied Data Entered
Apr 13, 2023
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
